<DOC>
	<DOCNO>NCT01611805</DOCNO>
	<brief_summary>This double-blind , single dose , four-period , crossover study Japanese healthy male volunteer assess pharmacokinetics safety/tolerability single dose GSK1605786A . Approximately 24 subject receive three treatment 250 , 500 , 1000mg GSK1605786 fast condition 500mg food intake plus placebo dose ascend crossover design . Serial pharmacokinetic sample collect follow dose safety assessment perform . The pharmacokinetics dose proportionality GSK1605786 single oral dos GSK1605786 dose level 250mg , 500mg 1000 mg fast condition assess . In addition , comparison make pharmacokinetics GSK1605786 feed fasted condition .</brief_summary>
	<brief_title>Japanese Phase I GSK1605786</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Healthy Japanese Japanese define born Japan , four ethnic Japanese grandparent , hold Japanese passport identity Male 20 55 year age inclusive , time signing informed consent . Body weight = &gt; 50kg BMI within range 18.5 25 kg/m2 ( inclusive ) . Known coeliac disease positive serologic test antitTG antibody ( require screen undiagnosed celiac disease )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>